ML20064F852
Jump to navigation
Jump to search
ML20064F852 | |
Person / Time | |
---|---|
Issue date: | 02/28/2020 |
From: | Russell Chazell NRC/SECY/RAS |
To: | |
Chazell, Russ, SECY | |
References | |
Download: ML20064F852 (1) | |
Text
Advisory Committee on the Medical Uses of Isotopes Membership Balance Plan
- 1. Committee Name: Advisory Committee on the Medical Uses of Isotopes (ACMUI)
- 2. Authority. Established pursuant to 42 United States Code §2201 as an NRC discretionary committee.
- 3. Mission/function. The Committee provides advice, as requested by the Director, Division of Materials Safety, Security, State, and Tribal Programs (MSST), Office of Nuclear Material Safety and Safeguards (NMSS), on policy and technical issues that arise in regulating the medical use of byproduct material for diagnosis and therapy. The Committee members may also serve as medical consultants, as requested by the Director, MSST.
- 4. Points of View. The membership of the Committee is comprised of 13 members, including health care professionals of diverse specialties who represent diagnostic and therapeutic applications of medicine, medical administration, and patient care advocacy.
All members of the Committee are appointed by the Director, NMSS as Special Government Employees.
- 5. Other Balance factors. None
- 6. Candidate Identification Process. Public announcements and Federal Register Notices are published seeking candidates for vacancies on the Committee. Professional Societies are contacted and encouraged to nominate candidates and solicit interest from their members. Submitted resumes are reviewed by a selection panel and the Director, MSST appoints members based upon the selection panels recommendations. The term of an appointment to the ACMUI is 4 years, and the Commission has determined that no member may serve more than 2 consecutive terms (8 consecutive years), unless otherwise approved by the Commission.
- 7. Subcommittee Balance. Subcommittee balance is achieved in the same manner as full committee balance, utilizing health care professionals of diverse specialties who represent diagnostic and therapeutic applications of medicine, medical administration, and patient care advocacy pertinent to the issues being considered by the subcommittee.
- 8. Date Prepared. February 2020